Phase I/II Study of Hepatic Arterial Infusion Chemotherapy With Gemcitabine in Patients With Unresectable Intrahepatic Cholangiocarcinoma (JIVROSG-0301)

American Journal of Clinical Oncology, 02/11/2011

Whereas the toxicity of hepatic arterial infusion with 1000 mg/m2 GEM for ICC was tolerable, expected efficacy could not be obtained, thus suggesting only minimal activity.

Print Article Summary Cat 2 CME Report